Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!Get your ComboX free sample to test now!
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Cat. No. | Especies | Descripción del producto | Estructura | Pureza | Característica |
---|---|---|---|---|---|
TFI-H5226 | Human | Human TFPI Protein, His Tag (active enzyme) |
|
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Concizumab | mAbTFPI2021; NN-7415; NNC-0172-0000-2021; Anti-TFPI; mAb-2021; NNC-0172-2021; NNC-172-2021 | Approved | Novo Nordisk A/S | Alhemo | Canada | Hemophilia B | Novo Nordisk Canada Inc | 2023-04-17 | Hemophilia A; Hemophilia B; Hemorrhage | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
KN-057 | KN-057; KN057 | Phase 3 Clinical | Suzhou Alphamab Co Ltd | Hemophilia A; Hemophilia B | Details |
MG-1113 | MG-1113 | Phase 1 Clinical | GC Biopharma Corp | Hemophilia A | Details |
AP-017 | AP017; AP-017 | Phase 1 Clinical | Anyuan Pharmaceutical Technology (Shanghai) Co Ltd | Hemophilia A; Hemophilia B | Details |
This web search service is supported by Google Inc.